Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-495 in Acute and Chronic Gastritis
NCT03437785Phase 2Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jan 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Artemisia argyi extract in gastritis, sponsored by Chong Kun Dang Holdings. Started Jan 2018; status: completed.
02
Drugs
Artemisia argyi extract
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT03437785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03437785.